195 related articles for article (PubMed ID: 3125739)
1. The cost of surveillance for adenocarcinoma complicating Barrett's esophagus.
Achkar E; Carey W
Am J Gastroenterol; 1988 Mar; 83(3):291-4. PubMed ID: 3125739
[TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
3. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
O'Connor JB; Falk GW; Richter JE
Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
[TBL] [Abstract][Full Text] [Related]
4. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
5. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
[TBL] [Abstract][Full Text] [Related]
6. The economic impact of the diagnosis of dysplasia in Barrett's esophagus.
Ofman JJ; Lewin K; Ramers C; Ippoliti A; Lieberman D; Weinstein W
Am J Gastroenterol; 2000 Oct; 95(10):2946-52. PubMed ID: 11051373
[TBL] [Abstract][Full Text] [Related]
7. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
Drewitz DJ; Sampliner RE; Garewal HS
Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
[TBL] [Abstract][Full Text] [Related]
8. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
9. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
10. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
11. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
12. [Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?].
Remes-Troche JM; Ramírez-Arias JF; Gómez-Escudero O; Valdovinos-Andraca F; Vargas-Vorácková F
Rev Gastroenterol Mex; 2006; 71(1):46-54. PubMed ID: 17061478
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma and Barrett's esophagus. An overrated risk?
Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
[TBL] [Abstract][Full Text] [Related]
16. Barrett's oesophagus: results from a 13-year surveillance programme.
Bani-Hani K; Sue-Ling H; Johnston D; Axon AT; Martin IG
Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):649-54. PubMed ID: 10912484
[TBL] [Abstract][Full Text] [Related]
17. Barrett's esophagus surveillance: When, how often, does it work?
Katona BW; Falk GW
Gastrointest Endosc Clin N Am; 2011 Jan; 21(1):9-24. PubMed ID: 21112494
[TBL] [Abstract][Full Text] [Related]
18. [Impact of endoscopic surveillance of Barrett's esophagus on survival of patients with esophageal adenocarcinoma].
Incarbone R; Bonavina L; Bassi F; Peracchia A
Chir Ital; 2002; 54(5):591-6. PubMed ID: 12469454
[TBL] [Abstract][Full Text] [Related]
19. [Adenocarcinoma in Barrett's esophagus. A retrospective study of 46 patients followed during 3.5 years].
Bujanda Fernández de Piérola L; Muñoz Villafranca C; Sánchez Martínez A; Iriondo Martínez de Luco C; Aras Portilla LM
An Med Interna; 1999 Apr; 16(4):178-80. PubMed ID: 10339842
[TBL] [Abstract][Full Text] [Related]
20. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study.
Vieth M; Schubert B; Lang-Schwarz K; Stolte M
Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
